{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05090345",
            "orgStudyIdInfo": {
                "id": "Pro00112697"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2021-11324",
                    "type": "OTHER",
                    "domain": "NCI-CTRP Clinical Trials Reporting Registry"
                }
            ],
            "organization": {
                "fullName": "Duke University",
                "class": "OTHER"
            },
            "briefTitle": "A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).",
            "officialTitle": "Prospective Multi Center Study of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-prospective-registry-of-pediatric-cellular-therapy-patients-at-risk-for-endothelial-dysfunction-sinusoidal-obstruction-syndrome-and-or-multi-organ-dysfunction-syndrome-mods"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-11-19",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-02-05",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-02-05",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-10-12",
            "studyFirstSubmitQcDate": "2021-10-12",
            "studyFirstPostDateStruct": {
                "date": "2021-10-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-12",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Duke University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a prospective international multi-center registry and biorepository trial of children and adolescents/young adults (AYA) undergoing hematopoietic cell transplantation (HCT) to assess the impact of endotheliopathies in the HCT setting as a contributor of significant morbidity and mortality.",
            "detailedDescription": "Primary:\n\n* To evaluate the proportion of pediatric patients undergoing hematopoietic cell transplant (HCT) who develop endotheliopathies (SOS, TMA, DAH and IPS) and/or MODS within 100 days of such therapies.\n* To evaluate the proportion of pediatric patients undergoing hematopoietic cell transplant (HCT) who experience abnormal levels of circulating angiogenic, vascular permeability and inflammatory factors within 100 days post HCT-CT in the setting of endotheliopathies.\n\nSecondary/Exploratory Objective(s):\n\n* To determine the impact of endotheliopathies in the HCT setting on the overall survival.\n* To assess the efficacy of specific prophylaxis and treatment strategies directed at endotheliopathies (SOS, TMA, DAH and IPS) post-HCT among enrolled children on overall survival.\n* To assess whether exposure to immunotherapies (CAR-T, PD-1 Inhibitors, bispecific T-cell engager (BiTE) antibodies and antibody drug conjugates) prior to HCT affects post-HCT outcomes (endotheliopathies and MODS)."
        },
        "conditionsModule": {
            "conditions": [
                "Hematopoietic Cell Transplantation"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 500,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Biorepository trial of children and adolescents/young adults (AYA)",
                    "description": "undergoing hematopoietic cell transplantation (HCT) to assess the impact of endotheliopathies in the HCT setting as a contributor of significant morbidity and mortality.",
                    "interventionNames": [
                        "Other: Biorepository Trial"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Biorepository Trial",
                    "description": "participating in this arm, peripheral blood specimen(s) will be obtained at 8 specified time-points.",
                    "armGroupLabels": [
                        "Biorepository trial of children and adolescents/young adults (AYA)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Proportion of pediatric patients undergoing hematopoietic cell transplant (HCT) who develop endotheliopathies (SOS, TMA, DAH and IPS) and/or MODS within 100 days of such therapies.",
                    "timeFrame": "through study completion, an average of 1 year"
                },
                {
                    "measure": "Proportion of pediatric patients undergoing (HCT) who experience abnormal levels of circulating angiogenic factors within 100 days post HCT-CT in the setting of endotheliopathies.",
                    "timeFrame": "through study completion, an average of 1 year"
                },
                {
                    "measure": "Proportion of pediatric patients undergoing (HCT) who experience abnormal levels of vascular permeability within 100 days post HCT-CT in the setting of endotheliopathies.",
                    "timeFrame": "through study completion, an average of 1 year"
                },
                {
                    "measure": "Proportion of pediatric patients undergoing (HCT) who experience abnormal levels of inflammatory factors within 100 days post HCT-CT in the setting of endotheliopathies.",
                    "timeFrame": "through study completion, an average of 1 year"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Overall survival.",
                    "timeFrame": "through study completion, an average of 1 year"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Children, adolescents and young adults (AYA) 0-26 years of age undergoing HSCT.\n* Recipients of autologous and allogeneic HSCT.\n* Any preparative regimen.\n\nExclusion Criteria:\n\n* Any patient who does not consent/assent to participation.\n* Any patient for whom 5 mL blood sample(s) drawn at specified intervals would pose any more than minimal risk, as defined by institutional guidelines and at discretion of treating physician will be ineligible for biorepository banking.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "0 Years",
            "maximumAge": "26 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ],
            "studyPopulation": "Children, adolescents and young adults (AYA) 0-26 years of age undergoing HSCT.",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "LaTarsha Spencer",
                    "role": "CONTACT",
                    "phone": "(919) 613-1895",
                    "email": "latarsha.spencer@duke.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Kris Mahadeo",
                    "affiliation": "Duke University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55902",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mira Kohorst",
                            "role": "CONTACT",
                            "email": "kohorst.mira@mayo.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                },
                {
                    "facility": "Duke University",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27705",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kris Mahadeo",
                            "role": "CONTACT",
                            "phone": "919-668-1180",
                            "email": "kris.mahadeo@duke.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dristhi Ragoonanan",
                            "role": "CONTACT",
                            "email": "DRagoonanan@mdanderson.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Duke University Medical Center",
                    "url": "http://www.dukehealth.org"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006504",
                    "term": "Hepatic Veno-Occlusive Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000008107",
                    "term": "Liver Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M9590",
                    "name": "Hepatic Veno-Occlusive Disease",
                    "asFound": "Sinusoidal Obstruction Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11107",
                    "name": "Liver Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2724",
                    "name": "Hepatic Veno-occlusive Disease",
                    "asFound": "Sinusoidal Obstruction Syndrome",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}